Q: What is Firazyr used for?

Firazyr is used to treat acute hereditary angioedema attacks.

Q: How does Firazyr work?

Mechanism of Action Hereditary angioedema (HAE) is a genetic condition characterized by sudden episodes of severe swelling. These attacks are driven by high levels of a protein called bradykinin. In a healthy body, bradykinin helps manage blood pressure and inflammation. However, during an HAE attack, the body produces too much bradykinin or cannot break it down properly. This excess bradykinin causes blood vessels to dilate and leak fluid into the surrounding tissues, leading to painful swelling in areas like the skin, abdomen, or throat. How Firazyr Intervenes Firazyr (icatibant) is designed to stop this process by targeting the specific receptors that bradykinin uses to send signals to the body. Its mechanism involves the following: Blocking Receptors: The medication acts as a bradykinin B2 receptor antagonist. It binds to the B2 receptors on the surface of cells, effectively blocking them. Preventing Fluid Leakage: By occupying these receptors, Firazyr prevents bradykinin from attaching to them. This stops the signal that tells blood vessels to release fluid into the tissues. Reducing Swelling: Once the signal is blocked, the leakage stops. This helps prevent the swelling from getting worse and allows the body to begin reabsorbing the excess fluid.

Q: What are the active ingredients in Firazyr?

The active ingredient in Firazyr is icatibant .

Q: What are the side effects of Firazyr?

Common side effects of Firazyr may include: injection site reactions fever dizziness Always consult with a healthcare professional about potential side effects.

Q: What drug class is Firazyr?

Firazyr belongs to the bradykinin B2 receptor antagonist drug class.

Q: What is the dosage of Firazyr and how do I take it?

Administration Method Firazyr is administered by subcutaneous injection, which is an injection into the fatty tissue just beneath the skin. The recommended site for injection is the stomach (abdomen) area. Each prefilled syringe is intended for a single use only. Usage During an Attack This medication should be used as soon as you notice symptoms of a hereditary angioedema attack. If your symptoms do not improve or if they come back after the first dose, additional doses may be administered. However, there is a maximum number of doses that can be safely used within a 24-hour period. Your healthcare provider will determine the appropriate frequency for your specific needs. Self-Injection and Training A healthcare professional can train you or a caregiver on how to properly prepare and inject Firazyr. You should only attempt to self-administer the medication after you have received this training and feel comfortable with the process. If you have an attack that affects your throat (laryngeal attack), you should seek immediate emergency medical care after injecting the medication, as these attacks can be life-threatening. Handling and Preparation Before injecting, always inspect the prefilled syringe. The liquid should be clear and colorless. If the solution is discolored, cloudy, or contains visible flakes or particles, do not use it and contact your pharmacist or healthcare provider. Missed Doses Because Firazyr is used only when needed for an acute attack, there is no regular dosing schedule. If you miss the opportunity to treat an attack early, administer the dose as soon as possible, provided it aligns with the frequency limits set by your doctor.

Q: Is Firazyr safe during pregnancy and breastfeeding?

Pregnancy There are no adequate and well-controlled studies of Firazyr in pregnant women to determine if there is a drug-associated risk of birth defects or miscarriage. In animal studies, high doses of the medication were associated with an increased risk of premature birth and pregnancy loss. Because human data are limited, healthcare providers typically only prescribe this medication during pregnancy if the potential benefit justifies the potential risk to the developing fetus. Breastfeeding It is not known whether Firazyr passes into human breast milk. While animal studies have shown that the drug can be excreted in the milk of lactating rats, its effects on a nursing human infant are unknown. Caution is advised when using this medication while breastfeeding, as many drugs are excreted in human milk. Consult Your Doctor If you are pregnant, planning to become pregnant, or are currently breastfeeding, it is important to discuss these factors with your healthcare provider. They can help evaluate the risks and benefits of continuing or starting treatment with this medication based on your specific medical needs and the severity of your condition.

Q: What forms and strengths does Firazyr come in?

Dosage Forms Firazyr is supplied as a liquid solution for injection. It is available in the following format: Prefilled Syringe: A single-use glass syringe containing a sterile, clear, and colorless liquid. The syringe is designed for subcutaneous administration, which involves injecting the medication into the fatty tissue of the stomach area. Each package includes a needle for the injection process.

Q: What is the FDA approval status of Firazyr?

FDA Approval History The U.S. Food and Drug Administration (FDA) approved Firazyr on August 25, 2011. It was approved as a subcutaneous injection for the treatment of acute attacks of hereditary angioedema (HAE). Approved Indications Firazyr is indicated for the treatment of acute attacks of hereditary angioedema in adults. It is intended to treat symptoms once an attack has started and is not approved for the chronic prevention of HAE attacks. The safety and efficacy of Firazyr in children or adolescents under the age of 18 have not been established by the FDA. Regulatory Safety Information Boxed Warnings: Firazyr does not have any FDA boxed warnings, which are the most serious safety warnings issued by the agency. REMS: The FDA does not require a Risk Evaluation and Mitigation Strategy (REMS) for Firazyr. Safety Communications: There are currently no active major safety communications or recalls documented for this medication in the provided regulatory sources.

Question 1

What is Firazyr?

Accepted Answer

Firazyr is a synthetic peptide that functions as a selective bradykinin B2 receptor antagonist. It works by blocking the activity of bradykinin, a substance in the body that promotes inflammation and causes blood vessels to leak fluid into surrounding tissues.

By inhibiting the interaction between bradykinin and its receptors, the medication helps to address the underlying biological processes that lead to acute episodes of localized swelling. This mechanism of action is intended to reduce the physiological response that causes fluid buildup in the body's tissues.

Question 2

What is Firazyr used for?

Accepted Answer

Firazyr is used to treat acute hereditary angioedema attacks.

Question 3

How does Firazyr work?

Accepted Answer

Mechanism of Action

Hereditary angioedema (HAE) is a genetic condition characterized by sudden episodes of severe swelling. These attacks are driven by high levels of a protein called bradykinin.

In a healthy body, bradykinin helps manage blood pressure and inflammation. However, during an HAE attack, the body produces too much bradykinin or cannot break it down properly. This excess bradykinin causes blood vessels to dilate and leak fluid into the surrounding tissues, leading to painful swelling in areas like the skin, abdomen, or throat.

How Firazyr Intervenes

Firazyr (icatibant) is designed to stop this process by targeting the specific receptors that bradykinin uses to send signals to the body. Its mechanism involves the following:

Blocking Receptors: The medication acts as a bradykinin B2 receptor antagonist. It binds to the B2 receptors on the surface of cells, effectively blocking them.
Preventing Fluid Leakage: By occupying these receptors, Firazyr prevents bradykinin from attaching to them. This stops the signal that tells blood vessels to release fluid into the tissues.
Reducing Swelling: Once the signal is blocked, the leakage stops. This helps prevent the swelling from getting worse and allows the body to begin reabsorbing the excess fluid.

Question 4

What are the active ingredients in Firazyr?

Accepted Answer

The active ingredient in Firazyr is icatibant.

Question 5

What are the side effects of Firazyr?

Accepted Answer

Common side effects of Firazyr may include:

injection site reactions
fever
dizziness

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Firazyr?

Accepted Answer

Firazyr belongs to the bradykinin B2 receptor antagonist drug class.

Question 7

What is the dosage of Firazyr and how do I take it?

Accepted Answer

Administration Method

Firazyr is administered by subcutaneous injection, which is an injection into the fatty tissue just beneath the skin. The recommended site for injection is the stomach (abdomen) area. Each prefilled syringe is intended for a single use only.

Usage During an Attack

This medication should be used as soon as you notice symptoms of a hereditary angioedema attack. If your symptoms do not improve or if they come back after the first dose, additional doses may be administered. However, there is a maximum number of doses that can be safely used within a 24-hour period. Your healthcare provider will determine the appropriate frequency for your specific needs.

Self-Injection and Training

A healthcare professional can train you or a caregiver on how to properly prepare and inject Firazyr. You should only attempt to self-administer the medication after you have received this training and feel comfortable with the process. If you have an attack that affects your throat (laryngeal attack), you should seek immediate emergency medical care after injecting the medication, as these attacks can be life-threatening.

Handling and Preparation

Before injecting, always inspect the prefilled syringe. The liquid should be clear and colorless. If the solution is discolored, cloudy, or contains visible flakes or particles, do not use it and contact your pharmacist or healthcare provider.

Missed Doses

Because Firazyr is used only when needed for an acute attack, there is no regular dosing schedule. If you miss the opportunity to treat an attack early, administer the dose as soon as possible, provided it aligns with the frequency limits set by your doctor.

Question 8

Is Firazyr safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of Firazyr in pregnant women to determine if there is a drug-associated risk of birth defects or miscarriage. In animal studies, high doses of the medication were associated with an increased risk of premature birth and pregnancy loss. Because human data are limited, healthcare providers typically only prescribe this medication during pregnancy if the potential benefit justifies the potential risk to the developing fetus.

Breastfeeding

It is not known whether Firazyr passes into human breast milk. While animal studies have shown that the drug can be excreted in the milk of lactating rats, its effects on a nursing human infant are unknown. Caution is advised when using this medication while breastfeeding, as many drugs are excreted in human milk.

Consult Your Doctor

If you are pregnant, planning to become pregnant, or are currently breastfeeding, it is important to discuss these factors with your healthcare provider. They can help evaluate the risks and benefits of continuing or starting treatment with this medication based on your specific medical needs and the severity of your condition.

Question 9

What forms and strengths does Firazyr come in?

Accepted Answer

Dosage Forms

Firazyr is supplied as a liquid solution for injection. It is available in the following format:

Prefilled Syringe: A single-use glass syringe containing a sterile, clear, and colorless liquid.

The syringe is designed for subcutaneous administration, which involves injecting the medication into the fatty tissue of the stomach area. Each package includes a needle for the injection process.

Question 10

What is the FDA approval status of Firazyr?

Accepted Answer

FDA Approval History

The U.S. Food and Drug Administration (FDA) approved Firazyr on August 25, 2011. It was approved as a subcutaneous injection for the treatment of acute attacks of hereditary angioedema (HAE).

Approved Indications

Firazyr is indicated for the treatment of acute attacks of hereditary angioedema in adults. It is intended to treat symptoms once an attack has started and is not approved for the chronic prevention of HAE attacks. The safety and efficacy of Firazyr in children or adolescents under the age of 18 have not been established by the FDA.

Regulatory Safety Information

Boxed Warnings: Firazyr does not have any FDA boxed warnings, which are the most serious safety warnings issued by the agency.
REMS: The FDA does not require a Risk Evaluation and Mitigation Strategy (REMS) for Firazyr.
Safety Communications: There are currently no active major safety communications or recalls documented for this medication in the provided regulatory sources.

Question 11

What should I know about Firazyr and cost?

Accepted Answer

Insurance and Generic Options

Firazyr is a specialty medication, and its price can be high. Many insurance providers require prior authorization before they will cover the cost. A generic version, icatibant, is available and may be less expensive than the brand-name drug depending on your insurance formulary.

Financial Support

Patients may be able to reduce their expenses through various programs:

Copay Cards: The manufacturer may provide copay assistance for patients with commercial insurance to lower their monthly out-of-pocket costs.
Patient Assistance Programs: These programs are often available for individuals who do not have insurance or who have limited coverage and meet certain financial criteria.

Because Firazyr is usually obtained through a specialty pharmacy rather than a standard retail pharmacy, it is helpful to contact the pharmacy or your insurance provider directly to get an accurate estimate of your specific costs.

Firazyr

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Firazyr

Hospitals.net Disclosure